NR1D1 and ovarian carcinoma: As SOCS3 has a low expression level in ovarian cancer tissues [40] and positively correlated with the level of NR1D1, we speculate that NR1D1 may influence the JAK/STAT3 signaling pathway as well as ovarian cancer cell growth through modulating SOCS3.